The role of p100 and ReIB in B lymphopoiesis
The role of p100 and ReIB in B lymphopoiesis
批准号:
24020230
负责人:
Professor Dr. Falk Weih (†)
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2011-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The NF-KB signal transduction pathway is known to be involved in innate and adaptive immune responses, inflammatory processes, the regulation of apoptosis and cancer. Recent reports indicate that NF-KB family members also control the development of T and B cells. However, it is not fully established whether NF-KB has important cell-autonomous functions in the development of early lymphocytes: that is before the expression of the pre-T cell receptor (pre- TCR) or the pre-B cell receptor (pre-BCR). In the proposed project we would like to investigate early B cell development in mice that lack the inhibitory p100 precursor of p52/NF-KB2. p100 has been shown to specifically block RelB and to play an important role in the activation of RelB/NF-KB via the recently described alternative pathway. Our initial results indicate that B cell development in pWO mice is arrested at the pro-B stage due to dramatically reduced Pax5 expression. After a more detailed characterization of the B cell developmental block in plOtf mice we plan to examine whether increased constitutive activation of RelB is responsible for the impaired B lymphopoiesis and whether B cell-specific and lineage-inappropriate genes are differentially expressed in B cell precursors from wild-type and p100^ mice. Since p100-deficient mice have myeloid hyperplasia and Pax5 represses myeloid-specific genes we also want to examine the lympho-myeloid differentiation potential of pWO^ pro-B cells. Finally, we attempt to rescue the B cell developmental block in p10Gf~ mice by ectopic expression of a Pax5 transgene. These studies should result in a better understanding of the role of NF-KB, in particular of p100, RelB, and the alternative pathway, in early B cell development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular analysis of RelB/NF-kappa-B transcription factors in development and function of lymphoid organs
-
批准号:5235165
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Falk Weih (†)
-
依托单位:
Rel/NF-kappaB in dendritic all development and function
-
批准号:5281522
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Falk Weih (†)
-
依托单位:
Biologie
-
批准号:5384363
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:Professor Dr. Falk Weih (†)
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ADSC外泌体通过MTI抑制染尘巨噬细胞NIK/IKKα/P100信号通路治疗矽肺的实验研究
-
批准号:81903268
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:李建忠
-
依托单位:
脂代谢相关基因烷基甘油酮磷酸核酶受Tudor-SN调控影响人神经胶质瘤增殖和侵袭的机制研究
-
批准号:31501159
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2015
-
负责人:朱彧
-
依托单位:
NFkB2 p100降解抑制剂治疗类风湿性关节炎的分子遗传基础
-
批准号:81373191
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2013
-
负责人:姚振强
-
依托单位:
POMC神经元中雌激素受体α-PI3K信号通路调节能量及葡萄糖平衡
-
批准号:81200623
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:朱良如
-
依托单位:
病毒感染中p100蛋白与I-dsRNA相互作用的分子机制研究
-
批准号:31170830
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:何津岩
-
依托单位:
人源调控转录共激活因子p100结构和功能的研究
-
批准号:30700123
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:Neil Shaw
-
依托单位:
转录激活因子-人类p100蛋白参与pre-mRNA剪接加工分子机制的研究
-
批准号:30670441
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:杨洁
-
依托单位: